Editor Yang-Hua Qin
Liting Chen, Xiaolu Long, Qian Xu, Jiaqi Tan, Gaoxiang Wang, Yang Cao, Jia Wei, Hui Luo, Hui Zhu, Liang Huang, Fankai Meng, Lifang Huang, Na Wang, Xiaoxi Zhou, Lei Zhao, Xing Chen, Zekai Mao, Caixia Chen, Zhen Li, Ziyong Sun, Jianping Zhao, Daowen Wang, Gang Huang, Wei Wang, Jianfeng Zhou
DOI: 10.1038/s41423-020-0492-x PubMed: 32620787
As a new infectious disease, the response mode of Acute-phase proteins one is of interesting focus in COVID-19. HMGB1's role in inflammation is unclear, but its potential role in diagnosis and monitoring the therapy effection is widely accepted.